Significant treatment attrition rate seen in multiple myeloma

by Elana GotkineThere is a significant treatment attrition rate in newly diagnosed multiple myeloma (NDMM), according to a study published in the November issue ofLeukemia & Lymphoma.Victor

Updated on: December 21,2023

Significant treatment attrition rate seen in multiple myeloma

by Elana GotkineThere is a significant treatment attrition rate in newly diagnosed multiple myeloma (NDMM), according to a study published in the November issue ofLeukemia & Lymphoma.Victor

Updated on:December 21,2023

Scientists uncover key mechanism linking microtubules and chemotherapy, enhancing cancer drug efficacy

Updated on: March 17,2025

Scientists uncover key mechanism linking microtubules and chemotherapy, enhancing cancer drug efficacy

Updated on:March 17,2025

Basic research opens up new therapeutic opportunities for fighting leukemia

byUniversity of Veterinary Medicine—ViennaGenome-wide CRISPR/Cas9-based loss-of-function screen identifies genetic dependencies of STAT3Y640F-driven cells a) Schematic illustration of a competit

Updated on: December 25,2023

Basic research opens up new therapeutic opportunities for fighting leukemia

byUniversity of Veterinary Medicine—ViennaGenome-wide CRISPR/Cas9-based loss-of-function screen identifies genetic dependencies of STAT3Y640F-driven cells a) Schematic illustration of a competit

Updated on:December 25,2023

Immunotherapy may become new first line treatment in some metastatic colorectal cancers

byEuropean Society for Medical OncologyCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Immunotherapy with nivolumab and low-dose ipilimumab could become a new fi

Updated on: December 18,2023

Immunotherapy may become new first line treatment in some metastatic colorectal cancers

byEuropean Society for Medical OncologyCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Immunotherapy with nivolumab and low-dose ipilimumab could become a new fi

Updated on:December 18,2023

Survival is a mixed matter for deadliest of pancreatic cancers

byUniversity of California - San DiegoPancreatic cancer cells (nuclei in blue) are shown growing as a sphere encased in membranes (red). Credit: National Cancer InstitutePancreatic ductal adenoc

Updated on: December 21,2023

Survival is a mixed matter for deadliest of pancreatic cancers

byUniversity of California - San DiegoPancreatic cancer cells (nuclei in blue) are shown growing as a sphere encased in membranes (red). Credit: National Cancer InstitutePancreatic ductal adenoc

Updated on:December 21,2023

How stress shapes cancer’s course

Studies show psychological strain can accelerate tumors — could beta blockers slow them down?

Updated on: April 08,2025

How stress shapes cancer’s course

Studies show psychological strain can accelerate tumors — could beta blockers slow them down?

Updated on:April 08,2025

Making glioblastoma more vulnerable to treatment

byMedical College of Georgia at Augusta UniversityDr. Waaqo Daddacha. Credit: Michael Holahan, Augusta UniversityIn the tough war against glioblastoma, scientists are taking a cue from viruses o

Updated on: January 04,2024

Making glioblastoma more vulnerable to treatment

byMedical College of Georgia at Augusta UniversityDr. Waaqo Daddacha. Credit: Michael Holahan, Augusta UniversityIn the tough war against glioblastoma, scientists are taking a cue from viruses o

Updated on:January 04,2024

Technology that determines success of CAR T-cell immunotherapy could advance treatment of lymphoma

by Laurie Fickman,University of HoustonNavin Varadarajan, M.D. Anderson Professor of chemical and biomolecular engineering, studied the dynamic interactions between T cells and tumor cells to de

Updated on: December 26,2023

Technology that determines success of CAR T-cell immunotherapy could advance treatment of lymphoma

by Laurie Fickman,University of HoustonNavin Varadarajan, M.D. Anderson Professor of chemical and biomolecular engineering, studied the dynamic interactions between T cells and tumor cells to de

Updated on:December 26,2023

New cell-based immunotherapy offered for melanoma

by Julia Evangelou Strait,Washington University School of Medicine in St. LouisCredit: Pixabay/CC0 Public DomainSiteman Cancer Center, based at Barnes-Jewish Hospital and Washington University S

Updated on: April 02,2024

New cell-based immunotherapy offered for melanoma

by Julia Evangelou Strait,Washington University School of Medicine in St. LouisCredit: Pixabay/CC0 Public DomainSiteman Cancer Center, based at Barnes-Jewish Hospital and Washington University S

Updated on:April 02,2024

Frailty score may predict outcomes in multiple myeloma

(HealthDay)—A frailty scale that includes Eastern Cooperative Oncology Group performance status (ECOG PS) may predict outcomes for transplant-ineligible patients with newly diagnosed multiple myeloma

Updated on: December 20,2023

Frailty score may predict outcomes in multiple myeloma

(HealthDay)—A frailty scale that includes Eastern Cooperative Oncology Group performance status (ECOG PS) may predict outcomes for transplant-ineligible patients with newly diagnosed multiple myeloma

Updated on:December 20,2023

Nine common questions about genetic testing for cancer

by Dan Lea,Mayo ClinicCredit: Pixabay/CC0 Public DomainYour genes play a role in nearly all areas of your health. A gene is like an instruction manual for your body that tells your body how to f

Updated on: December 22,2023

Nine common questions about genetic testing for cancer

by Dan Lea,Mayo ClinicCredit: Pixabay/CC0 Public DomainYour genes play a role in nearly all areas of your health. A gene is like an instruction manual for your body that tells your body how to f

Updated on:December 22,2023

RXR, the cell protein that keeps blood stem cells young and fit

RXR, the cell protein that keeps blood stem cells young and fitby Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)Bone marrow histology in a normal mouse and in a mouse lacking

Updated on: October 29,2023

RXR, the cell protein that keeps blood stem cells young and fit

RXR, the cell protein that keeps blood stem cells young and fitby Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)Bone marrow histology in a normal mouse and in a mouse lacking

Updated on:October 29,2023